Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 11/20 | 0.50 |
| ▸ | AGTR2 | P50052 | 11/20 | 0.50 |
| ▸ | APLNR | P35414 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8117079 | 0.96 | AGTR1 (0.45) | AGTR1AGTR2 | |
| SCHEMBL8117907 | 0.94 | AGTR1 (0.50) | AGTR1AGTR2APLNR | |
| SCHEMBL8115995 | 0.94 | AGTR1 (0.44) | AGTR1AGTR2 | |
| SCHEMBL8123882 | 0.94 | AGTR1 (0.56) | AGTR1AGTR2 | |
| SCHEMBL8115310 | 0.91 | AGTR1 (0.49) | AGTR1AGTR2APLNR | |
| SCHEMBL8114897 | 0.91 | AGTR1 (0.52) | AGTR1AGTR2 | |
| SCHEMBL8117448 | 0.91 | AGTR1 (0.42) | AGTR1AGTR2 | |
| SCHEMBL8116047 | 0.91 | AGTR1 (0.48) | AGTR1AGTR2 | |
| SCHEMBL8106473 | 0.91 | AGTR1 (0.52) | AGTR1AGTR2 | |
| SCHEMBL8114205 | 0.91 | AGTR1 (0.52) | AGTR1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0664802-B1 | N-ARYLHETEROARYLALKYL 1-PHENYL-IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS | SEARLE & CO (US) | 2000-03-15 | — | — | EP | disclosed |
| EP-0664802-A1 | N-ARYLHETEROARYLALKYL 1-PHENYL-IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS | G.D. SEARLE & CO. (US) | 1995-08-02 | — | — | EP | disclosed |
| WO-1994008990-A1 | N-ARYLHETEROARYLALKYL 1-PHENYL-IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS | G.D. SEARLE & CO. (US) | 1994-04-28 | — | — | WO | disclosed |